Biotech China 2014

Cell Biology: Merck

Total Score People Score Events Score
52 45 40
Date Event Presentation Speakers
February 3, 2013 Neurogenesis (J7) Mechanisms of Early Disease Intervention and Biomarkers Michael L. Hutton
February 3, 2013 New Frontiers in Neurodegenerative Disease Research (J8) Mechanisms of Early Disease Intervention and Biomarkers Michael L. Hutton
Tau-based Therapeutics for Alzheimer’s Disease and Related Tauopathies Michael L. Hutton
January 30, 2013 Pharmaceutical Microbiology Molecular biology methods for viral safety: danger tool or perfect solution Emiliano Toso
February 20, 2012 Advances and Progress in Drug Design Noticing the unnoticed: bridging structural data and drug design Jose Duca
Biophysics in drug discovery: integrative use of structural, kinetic and thermodynamic data Matthias Frech
November 29, 2011 The 7th annual European Antibody Congress is the worldleading conference addressing critical scientific issues and strategic industry challenges associated with therapeutic mAb development. Path to clinical development of Anticalins and other new scaffolds Laurent Audoly
August 25, 2010 Co-Development of Drugs and Diagnostics Choosing a Biomarker Partner Cynthia Gawron-Burke
July 11, 2010 Translational Cancer Medicine 2010 (USA) The biomarker roadmap: How to integrate biomarker and compound discovery for early clinical decision making Pearl S. Huang
Why current ways of working together as patients, clinicians, and scientists could ultimately fail Stephen H Friend
June 23, 2010 Structure-Based Drug Design TABLE 4: Do We Get the Most Out of the Structural information in the PDB? Tips and Lessons Learned José Duca
Chairperson’s Remarks José Duca
May 19, 2010 Towards Personalized Cancer Medicine Integrative Genomic Models of Disease, Use of Contributor Networks Stephen H Friend
SESSION IV: Biomarkers for Prognosis/Response: Impact on Clinical Trials Stephen H Friend
Molecular Profiling of Pre-Clinical and Clinical Models: Informing the Development of Rational Combinations James Watters
May 4, 2010 Biomarker World Congress 2010 Identification of a Transcriptional Biomarker of Target Engagement and Use in Oncology Early Clinical Development Samuel C. Blackman
Practice and Pitfalls of Open Source Precompetitive Collaboration on Biomarkers John A. Wagner
From Biomarker Strategies to Biomarker Activities and Back Alain van Gool
April 28, 2010 Kinase Inhibitor Chemistry Featured Presentation Discovery of Novel Kinase Inhibitors Using Structure-Based Design Jose Duca
October 13, 2009 Fourth Annual Drug Repositioning Summit Knowledge Management Technologies for Drug Repurposing Natalia Novac
September 24, 2009 Track 4: Bridging Silos in Biomarker Development : Seventh Annual Protein Biomarkers Proteomics - From Basic Research to the Clinic Ronald C. Hendrickson
September 23, 2009 TRACK 4: Bridging Silos in Biomarker Development : Third Annual Biomarker Data Analysis IT Frameworks for Supporting Analysis of Complex Data Sets in Translational Medicine Research Gary K. Mallow
August 18, 2009 Second Annual Pre-Clinical/Clinical Development of Immunotherapies and Vaccines Risk Management in Vaccine Development Programs Adrian Dana
August 10, 2009 Second Annual Trends in Cancer Diagnostics Cancer Biomarkers to Predict Therapeutic Response Cynthia Gawron-Burke
August 5, 2009 Drug Safety Strategies to De-Risk Compounds An in vitro and in vivo Evaluation of the Off-Target Profile of the CETP Inhibitor, Torcetrapib Michael J. Forest
June 22, 2009 Collaborative Innovation in Biomedicine Taking a Pre-Competitive Approach to Defining Standards and Leveraging Best Practices to Enable Basic Research Collaboration Martin D. Leach
Solutions for Facilitating Data Sharing in Collaborative Research Martin D. Leach
The Future of Pre-Competitive Consortia – A Best Practices Panel Discussion Martin D. Leach
June 10, 2009 Second Annual Hepatotoxicity and Drug Safety In Vitro - In Vivo Correlations of Drug-Induced Liver Injury Jinghai Xu
Investigation of Drug-Induced Hepatotoxicity from a Drug Metabolism Perspective Wei Tang
June 9, 2009 Genomic Sample Prep Development of a Microarray Platform for FFPET Profiling: Application to the Classification of Human Tumors Mingjie Zhou
June 9, 2009 RNAi for Target Identification and Validation A High-Throughput Chemical Biology Approach to Identify Modulators of the Hypoxia Inducible Factor (HIF) Pathway Marc Ferrer
June 9, 2009 Cell and Tissue-Based Assays for HTS Data Analysis in RNAi High-Throughput Screens Xiaohua Douglas Zhang
Evaluation of Putative GPCR Antagonists Using the CellKey System David J. Bell, Department of Automated Biotechnology, Merck & Company David J. Bell
March 9, 2009 Drug Development Latin America Organizer’s Welcome and Chairperson’s Remarks Jorge Rodriguez Larrain
Chairperson’s Remarks Jorge Rodriguez Larrain
Adaptative Designs (Phase I - III): Regulatory Challenges and Opportunities in Latin America Jorge Rodriguez Larrain
February 23, 2009 Advances and Progress in Drug Design VIII KNOWLEDGE BASED DRUG DESIGN Matthias Frech
January 28, 2009 Electronic Laboratory Notebooks INTEGRATION OF ANALYTICAL WORKFLOW INTO ELNs : Supporting the research chemists with valid information and data Jan Hauß
April 6, 2008 Islet and Beta Cell Development and Transplantation Mechanisms of Beta-Cell Failure In Disease and Possible Drug Targets Nancy A. Thornberry
March 25, 2008 PATHWAY ANALYSIS Innovative Medicines for Europe Phil Hewitt
March 25, 2008 THE STEM CELLS CONGRESS Chairperson’s Remarks Huseyin Mehmet
March 9, 2008 NEW ANTIBACTERIAL DISCOVERY & DEVELOPMENT New strategies to develop novel targets: Platensimycin, a selective FabF inhibitor Sheo B Singh
February 7, 2008 Cell Death and Cellular Senescence Regulation of Apoptosis (Joint) Donald W. Nicholson
January 13, 2008 Leukocyte Trafficking Keynote Session (Joint) Amanda E.I Proudfoot Fichard
January 13, 2008 Chemokines and Chemokine Receptors Keynote Session (Joint) Amanda E.I Proudfoot Fichard
December 4, 2007 7th World Drug Discovery & Development Summit 2007 Conference room 2 PREDICTIVE TOXICITY SCREENING PRIOR TO DEVELOPMENT Dr. Stefan Otto Mueller
Conference room 2 HIGH CONTENT SCREENING Jinghai Xu
November 7, 2007 Srial II: Advances and Challenges Toward Major Diseases: Extension on New Hope Nov (07-13) Session 1: Keynote Forum (09:30 -12:00) Dr. Bharatt M. Chowrira
Session 1: Embracing Cross-Border Alliances to Expand and Advance Drug Discovery Activities (10:00-10:30) Dr. Bharatt M. Chowrira
Session 4: (Part One) Anti-Infectious Drug Discovery & Development (I) (Part Two) RNAi & Gene: Applications in Drug Discovery and Therapeutics (13:30-17:05) Dr. Bharatt M. Chowrira
Session 4: RNAi-Based Therapeutics- The Promise and Challenges (15:00-15:20) Dr. Bharatt M. Chowrira
Session 9: Innovative Metabolic Diseases Drug Discovery & Development (13:30-17:05) Ruojing Yang
Session 9: RNA Interference for Target Identification and Validation (13:30-13:50) Ruojing Yang
October 17, 2007 Inaugral Nuclear Harmone Receptors Modulators: Targets for Drug Discovery Oct (17-18) DISCOVERY CHEMISTRY (08:35-12:55) H. Blair Wood
DISCOVERY CHEMISTRY: Selective PPAR gamma Modulators for the Treatment of Type 2 Diabetes (09:10-09:40) H. Blair Wood
October 16, 2007 Fifth Annual RNAi for Drug Discovery and Therapeutics - Best Practices from the Bench to the Clinic Oct (16-17) In vitro RNAi Screening Strategies (08:30-10:40) Marc Ferrer
In vitro RNAi Screening Strategies: Genome-Wide siRNA HTS: Multi-readout and Multi-temporal Assays to Identify Physiologically Relevant Genes (09:10-09:40) Marc Ferrer
Keynote Introduction; Executive Panel: Delivering Drugs for Difficult Targets (08:40-09:40) Lex Van der Ploeg, Shama Kajiji
October 15, 2007 Cambridge Healthtech Institute's Third Annual Mastering Process Chemistry Oct (15-17) CASE STUDIES OF PRACTICAL SYNTHESIS (13:30-18:30) Cheng-yi Chen
CASE STUDIES OF PRACTICAL SYNTHESIS: Catalytic, Enantioselective Synthesis of Taranabant, a Novel, Acyclic Cannabinoid-1 Receptor Inverse Agonist for the Treatment of Obesity (14:40-15:10) Cheng-yi Chen
BIOCATALYSIS FOR CHEMICAL PROCESS DEVELOPMENT: Biocatalysis in Process Research (09:00-09:30) Paul N. Devine
October 11, 2007 Compound Profiling & Chemogenomic Approaches to Drive Decision Making and Predict Clinical Adverse Effects (Oct 11-12) PROFILING TO OPTIMIZE EFFICACY (08:30-14:00) Berta Strulovici
PROFILING TO OPTIMIZE EFFICACY: Panel Discussion - The Value of Doing Systems Biology after HTS (12:15-12:45) Berta Strulovici
September 17, 2007 Optimizing Cell Culture Development (Sep17-18) OPTIMIZING YIELD: Integrated Approach of Product Characterization for Cell Line Screening & Development (12:10-12:40) Chrstine P. Chan
OPTIMIZING YIELD (10:50-12:40) Chrstine P. Chan
September 17, 2007 Biomarker Discovery Summit: Bridging the Silos in Biomarker Discovery & Validation (Sep17-19) Eight Annual Metabolic Biomarkers; METABOLITE BIOMARKERS OF TOXICITY (13:30-15:00) Qiuwei Xu
Eight Annual Metabolic Biomarkers; METABOLITE BIOMARKERS OF TOXICITY: NMR Metabolomics: Metabolites, Mechanisms, and Pathways (13:30-14:00) Qiuwei Xu
Third Annual Toxicity Biomarkers; METABOLITE BIOMARKERS OF TOXICITY: NMR Metabolomics: Metabolites, Mechanisms, and Pathways (13:30-14:00) Qiuwei Xu
Third Annual Toxicity Biomarkers; METABOLITE BIOMARKERS OF TOXICITY (13:30-15:00) Qiuwei Xu
Biotech China 2014
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.